Literature DB >> 28912081

Towards understanding rTMS mechanism of action: Stimulation of the DLPFC causes network-specific increase in functional connectivity.

Martin Tik1, André Hoffmann1, Ronald Sladky1, Livia Tomova2, Allan Hummer1, Lucia Navarro de Lara1, Henryk Bukowski2, Jürgen Pripfl2, Bharat Biswal3, Claus Lamm2, Christian Windischberger4.   

Abstract

Transcranial magnetic stimulation (TMS) is a powerful non-invasive technique for the modulation of brain activity. While the precise mechanism of action is still unknown, TMS is applied in cognitive neuroscience to establish causal relationships between stimulation and subsequent changes in cerebral function and behavioral outcome. In addition, TMS is an FDA-approved therapeutic agent in psychiatric disorders, especially major depression. Successful repetitive TMS in such disorders is usually applied over the left dorso-lateral prefrontal cortex (DLPFC) and treatment response mechanism was therefore supposed to be based on modulations in functional networks, particularly the meso-cortico-limbic reward circuit. However, mechanistic evidence for the direct effects of rTMS over DLPFC is sparse. Here we show the specificity and temporal evolution of rTMS effects by comparing connectivity changes within 20 common independent components in a sham-controlled study. Using an unbiased whole-brain resting-state network (RSN) approach, we successfully demonstrate that stimulation of left DLPFC modulates anterior cingulate cortex (ACC) connectivity in one specific meso-cortico-limbic network, while all other networks are neither influenced by rTMS nor by sham treatment. The results of this study show that the neural correlates of TMS treatment response are also traceable in DLPFC stimulation of healthy brains and therefore represent direct effects of the stimulation procedure.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  1000 Functional connectomes project; Clinical application; ICA; Resting-state; TMS

Mesh:

Year:  2017        PMID: 28912081     DOI: 10.1016/j.neuroimage.2017.09.022

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  43 in total

1.  A multivariate neuroimaging biomarker of individual outcome to transcranial magnetic stimulation in depression.

Authors:  Robin F H Cash; Luca Cocchi; Rodney Anderson; Anton Rogachov; Aaron Kucyi; Alexander J Barnett; Andrew Zalesky; Paul B Fitzgerald
Journal:  Hum Brain Mapp       Date:  2019-07-22       Impact factor: 5.038

2.  Changes in Functional Connectivity Predict Outcome of Repetitive Transcranial Magnetic Stimulation Treatment of Major Depressive Disorder.

Authors:  Juliana Corlier; Andrew Wilson; Aimee M Hunter; Nikita Vince-Cruz; David Krantz; Jennifer Levitt; Michael J Minzenberg; Nathaniel Ginder; Ian A Cook; Andrew F Leuchter
Journal:  Cereb Cortex       Date:  2019-12-17       Impact factor: 5.357

3.  A Clinical Program to Implement Repetitive Transcranial Magnetic Stimulation for Depression in the Department of Veterans Affairs.

Authors:  Whitney T Carrico; Gerald Georgette; Michelle R Madore; F Andrew Kozel; Mark S George; Steven Lindley; Steven Lovett; Jong H Yoon; Jerome A Yesavage
Journal:  Fed Pract       Date:  2020-06

4.  Using diffusion tensor imaging to effectively target TMS to deep brain structures.

Authors:  Bruce Luber; Simon W Davis; Zhi-De Deng; David Murphy; Andrew Martella; Angel V Peterchev; Sarah H Lisanby
Journal:  Neuroimage       Date:  2021-12-30       Impact factor: 6.556

5.  Genetic profile for dopamine signaling predicts brain functional reactivity to repetitive transcranial magnetic stimulation.

Authors:  Haejin Hong; Rye Young Kim; Soo Mee Lim; Suji Lee; Yumi Song; Chaewon Suh; Hyangwon Lee; In Kyoon Lyoo; Sujung Yoon
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-08-11       Impact factor: 5.760

6.  Use of high-frequency repetitive transcranial magnetic stimulation to probe the neural circuitry of food choice in anorexia nervosa: A proof-of-concept study.

Authors:  Alexandra F Muratore; Mariya Bershad; Joanna E Steinglass; Karin E Foerde; Loren Gianini; Allegra Broft; Evelyn Attia
Journal:  Int J Eat Disord       Date:  2021-08-20       Impact factor: 5.791

Review 7.  Precise Modulation Strategies for Transcranial Magnetic Stimulation: Advances and Future Directions.

Authors:  Gangliang Zhong; Zhengyi Yang; Tianzi Jiang
Journal:  Neurosci Bull       Date:  2021-10-05       Impact factor: 5.203

8.  Transcriptome-based polygenic score links depression-related corticolimbic gene expression changes to sex-specific brain morphology and depression risk.

Authors:  Amy E Miles; Fernanda C Dos Santos; Enda M Byrne; Miguel E Renteria; Andrew M McIntosh; Mark J Adams; Giorgio Pistis; Enrique Castelao; Martin Preisig; Bernhard T Baune; K Oliver Schubert; Cathryn M Lewis; Lisa A Jones; Ian Jones; Rudolf Uher; Jordan W Smoller; Roy H Perlis; Douglas F Levinson; James B Potash; Myrna M Weissman; Jianxin Shi; Glyn Lewis; Brenda W J H Penninx; Dorret I Boomsma; Steven P Hamilton; Etienne Sibille; Ahmad R Hariri; Yuliya S Nikolova
Journal:  Neuropsychopharmacology       Date:  2021-09-29       Impact factor: 7.853

9.  Unchanged Cognitive Performance and Concurrent Prefrontal Blood Oxygenation After Accelerated Intermittent Theta-Burst Stimulation in Depression: A Sham-Controlled Study.

Authors:  Wiebke Struckmann; Jonas Persson; Malin Gingnell; Wojciech Weigl; Caroline Wass; Robert Bodén
Journal:  Front Psychiatry       Date:  2021-06-30       Impact factor: 4.157

10.  Repetitive transcranial magnetic stimulation (rTMS) in autism spectrum disorder: protocol for a multicentre randomised controlled clinical trial.

Authors:  Peter G Enticott; Karen Barlow; Adam J Guastella; Melissa K Licari; Nigel C Rogasch; Christel M Middeldorp; Scott R Clark; Ann-Maree Vallence; Kelsie A Boulton; Ian B Hickie; Andrew J O Whitehouse; Cherrie Galletly; Gail A Alvares; Hakuei Fujiyama; Helen Heussler; Jeffrey M Craig; Melissa Kirkovski; Natalie T Mills; Nicole J Rinehart; Peter H Donaldson; Talitha C Ford; Karen Caeyenberghs; Natalia Albein-Urios; Soukayna Bekkali; Paul B Fitzgerald
Journal:  BMJ Open       Date:  2021-07-07       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.